Cargando…

Chronic Kidney Disease–Induced Vascular Calcification Impairs Bone Metabolism

An association between lower bone mineral density (BMD) and presence of vascular calcification (VC) has been reported in several studies. Chronic kidney disease (CKD) causes detrimental disturbances in the mineral balance, bone turnover, and development of severe VC. Our group has previously demonst...

Descripción completa

Detalles Bibliográficos
Autores principales: Mace, Maria L, Gravesen, Eva, Nordholm, Anders, Egstrand, Soeren, Morevati, Marya, Nielsen, Carsten, Kjaer, Andreas, Behets, Geert, D'Haese, Patrick, Olgaard, Klaus, Lewin, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988613/
https://www.ncbi.nlm.nih.gov/pubmed/33301619
http://dx.doi.org/10.1002/jbmr.4203
_version_ 1783668818235621376
author Mace, Maria L
Gravesen, Eva
Nordholm, Anders
Egstrand, Soeren
Morevati, Marya
Nielsen, Carsten
Kjaer, Andreas
Behets, Geert
D'Haese, Patrick
Olgaard, Klaus
Lewin, Ewa
author_facet Mace, Maria L
Gravesen, Eva
Nordholm, Anders
Egstrand, Soeren
Morevati, Marya
Nielsen, Carsten
Kjaer, Andreas
Behets, Geert
D'Haese, Patrick
Olgaard, Klaus
Lewin, Ewa
author_sort Mace, Maria L
collection PubMed
description An association between lower bone mineral density (BMD) and presence of vascular calcification (VC) has been reported in several studies. Chronic kidney disease (CKD) causes detrimental disturbances in the mineral balance, bone turnover, and development of severe VC. Our group has previously demonstrated expression of Wnt inhibitors in calcified arteries of CKD rats. Therefore, we hypothesized that the CKD‐induced VC via this pathway signals to bone and induces bone loss. To address this novel hypothesis, we developed a new animal model using isogenic aorta transplantation (ATx). Severely calcified aortas from uremic rats were transplanted into healthy rats (uremic ATx). Transplantation of normal aortas into healthy rats (normal ATx) and age‐matched rats (control) served as control groups. Trabecular tissue mineral density, as measured by μCT, was significantly lower in uremic ATx rats compared with both control groups. Uremic ATx rats showed a significant upregulation of the mineralization inhibitors osteopontin and progressive ankylosis protein homolog in bone. In addition, we found significant changes in bone mRNA levels of several genes related to extracellular matrix, bone turnover, and Wnt signaling in uremic ATx rats, with no difference between normal ATx and control. The bone histomorphometry analysis showed significant lower osteoid area in uremic ATx compared with normal ATx along with a trend toward fewer osteoblasts as well as more osteoclasts in the erosion lacunae. Uremic ATx and normal ATx had similar trabecular number and thickness. The bone formation rate did not differ between the three groups. Plasma biochemistry, including sclerostin, kidney, and mineral parameters, were similar between all three groups. ex vivo cultures of aorta from uremic rats showed high secretion of the Wnt inhibitor sclerostin. In conclusion, the presence of VC lowers BMD, impairs bone metabolism, and affects several pathways in bone. The present results prove the existence of a vasculature to bone tissue cross‐talk. © 2020 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).
format Online
Article
Text
id pubmed-7988613
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-79886132021-03-29 Chronic Kidney Disease–Induced Vascular Calcification Impairs Bone Metabolism Mace, Maria L Gravesen, Eva Nordholm, Anders Egstrand, Soeren Morevati, Marya Nielsen, Carsten Kjaer, Andreas Behets, Geert D'Haese, Patrick Olgaard, Klaus Lewin, Ewa J Bone Miner Res Original Articles An association between lower bone mineral density (BMD) and presence of vascular calcification (VC) has been reported in several studies. Chronic kidney disease (CKD) causes detrimental disturbances in the mineral balance, bone turnover, and development of severe VC. Our group has previously demonstrated expression of Wnt inhibitors in calcified arteries of CKD rats. Therefore, we hypothesized that the CKD‐induced VC via this pathway signals to bone and induces bone loss. To address this novel hypothesis, we developed a new animal model using isogenic aorta transplantation (ATx). Severely calcified aortas from uremic rats were transplanted into healthy rats (uremic ATx). Transplantation of normal aortas into healthy rats (normal ATx) and age‐matched rats (control) served as control groups. Trabecular tissue mineral density, as measured by μCT, was significantly lower in uremic ATx rats compared with both control groups. Uremic ATx rats showed a significant upregulation of the mineralization inhibitors osteopontin and progressive ankylosis protein homolog in bone. In addition, we found significant changes in bone mRNA levels of several genes related to extracellular matrix, bone turnover, and Wnt signaling in uremic ATx rats, with no difference between normal ATx and control. The bone histomorphometry analysis showed significant lower osteoid area in uremic ATx compared with normal ATx along with a trend toward fewer osteoblasts as well as more osteoclasts in the erosion lacunae. Uremic ATx and normal ATx had similar trabecular number and thickness. The bone formation rate did not differ between the three groups. Plasma biochemistry, including sclerostin, kidney, and mineral parameters, were similar between all three groups. ex vivo cultures of aorta from uremic rats showed high secretion of the Wnt inhibitor sclerostin. In conclusion, the presence of VC lowers BMD, impairs bone metabolism, and affects several pathways in bone. The present results prove the existence of a vasculature to bone tissue cross‐talk. © 2020 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). John Wiley & Sons, Inc. 2020-12-10 2021-03 /pmc/articles/PMC7988613/ /pubmed/33301619 http://dx.doi.org/10.1002/jbmr.4203 Text en © 2020 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Mace, Maria L
Gravesen, Eva
Nordholm, Anders
Egstrand, Soeren
Morevati, Marya
Nielsen, Carsten
Kjaer, Andreas
Behets, Geert
D'Haese, Patrick
Olgaard, Klaus
Lewin, Ewa
Chronic Kidney Disease–Induced Vascular Calcification Impairs Bone Metabolism
title Chronic Kidney Disease–Induced Vascular Calcification Impairs Bone Metabolism
title_full Chronic Kidney Disease–Induced Vascular Calcification Impairs Bone Metabolism
title_fullStr Chronic Kidney Disease–Induced Vascular Calcification Impairs Bone Metabolism
title_full_unstemmed Chronic Kidney Disease–Induced Vascular Calcification Impairs Bone Metabolism
title_short Chronic Kidney Disease–Induced Vascular Calcification Impairs Bone Metabolism
title_sort chronic kidney disease–induced vascular calcification impairs bone metabolism
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988613/
https://www.ncbi.nlm.nih.gov/pubmed/33301619
http://dx.doi.org/10.1002/jbmr.4203
work_keys_str_mv AT macemarial chronickidneydiseaseinducedvascularcalcificationimpairsbonemetabolism
AT graveseneva chronickidneydiseaseinducedvascularcalcificationimpairsbonemetabolism
AT nordholmanders chronickidneydiseaseinducedvascularcalcificationimpairsbonemetabolism
AT egstrandsoeren chronickidneydiseaseinducedvascularcalcificationimpairsbonemetabolism
AT morevatimarya chronickidneydiseaseinducedvascularcalcificationimpairsbonemetabolism
AT nielsencarsten chronickidneydiseaseinducedvascularcalcificationimpairsbonemetabolism
AT kjaerandreas chronickidneydiseaseinducedvascularcalcificationimpairsbonemetabolism
AT behetsgeert chronickidneydiseaseinducedvascularcalcificationimpairsbonemetabolism
AT dhaesepatrick chronickidneydiseaseinducedvascularcalcificationimpairsbonemetabolism
AT olgaardklaus chronickidneydiseaseinducedvascularcalcificationimpairsbonemetabolism
AT lewinewa chronickidneydiseaseinducedvascularcalcificationimpairsbonemetabolism